An open single arm clinical trial to determine the therapeutic effect of Attai vidal (Leech therapy) in the management of Narithalai Vaatham (Gouty Arthritis)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- 0 Good improvement
研究概览
简要总结
OBJECTIVES:
To determine the therapeutic effect of leech therapy in the management of
Narithalai vatham (Gouty arthritis)
To evaluate the improvement of clinical signs and symptoms of Narithalai
vatham (Gouty arthritis) participants before and after treatment of leech
application.
To study the Siddha basic principles towards effect of Leech therapy.
METHODOLOGY:
STUDY DESIGN : An open single arm clinical trial
STUDY TYPE : Interventional study
STUDY PLACE : Ayothidoss Pandithar Hospital,National Institute of Siddha,
Tambaram Sanatorium, Chennai-47.
STUDY SIZE : 20 participants
STUDY PERIOD : 18 months
STUDY INTERVENTION : Attaividal
INCLUSION CRITERIA:
Age 20-65 years
All genders.
Having classical symptoms of gout- intense pain, tenderness, swelling, redness and
warmth and limitation of movements
EXCLUSION CRITERIA:
Participants with h/o uncontrolled Diabetes and Hypertension
Participants of bleeding disorders such as hemophilia, platelet disorder, capillary
bleeding and severe anemia
Immunocompromised patients such as AIDS, Cancer, SLE.
Pregnancy and lactation
Psychiatric illness
WITHDRAWAL CRITERIA:
Intolerance to leech therapy and development of any serious adverse reactions during
this trial Period clinical ASSESSMENT:
The classical presentation is with an acute mono arthritis, which affects the first
metatarsal phalangeal joint. other common sites are ankle, midfoot, knee, small joints
of hands, wrist and elbow.
Severe pain, swelling and warmth in thew affected joints.
Affected joints are warm, red and swollen.
Mild fever may be present
Tophi may be present in chronic, severe disease.OUTCOME:
The outcome of the study may reveal the therapeutic effect of Attaividal (Leech therapy) in
the management of Narithalai vatham (Gouty arthritis) assessing with the Visual Analogue
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •• Age 30-65 years • All genders.
- •• Having classical symptoms of gout- development of maximal inflammation within one day, joint redness, pain, hyperuricemia, suspected tophus, attack of monoarticular arthritis, unilateral attack involving tarsal joint or first metatarsophalangeal joint, more than one attack of acute arthritis and subcortical cyst without erosions (presence of 6 or more findings will be included in the study).
排除标准
- •Participants with h/o uncontrolled Diabetes and Hypertension Participants with any bleeding abnormality while taking BT, CT.
- •Immunocompromised patients such as AIDS, Cancer, SLE.
- •• Pregnancy and lactation • Psychiatric illness • Septic arthritis, cellulitis, pseudo gout, and trauma.
- •• Participants with anemia.
结局指标
主要结局
0 Good improvement
时间窗: Baseline, each week until 8 week
1-3 Moderate improvement
时间窗: Baseline, each week until 8 week
4-6 Mild improvement
时间窗: Baseline, each week until 8 week
7-10 No improvement
时间窗: Baseline, each week until 8 week
I. VISUAL ANALOG SCALE:
时间窗: Baseline, each week until 8 week
The outcome of the study may reveal the therapeutic effect of Attaividal (Leech therapy) in the management of Narithalai vatham (Gouty arthritis) assessing with the Visual Analogue Scale.A) Range of the score:
时间窗: Baseline, each week until 8 week
0 No pain
时间窗: Baseline, each week until 8 week
1-3 occasionally pain
时间窗: Baseline, each week until 8 week
4-6 Moderate pain
时间窗: Baseline, each week until 8 week
7-10 Severe pain
时间窗: Baseline, each week until 8 week
OUTCOME OF THE SCORE:
时间窗: Baseline, each week until 8 week
次要结局
- Improvement in quality of life
研究者
Dr A ANBARASI
National Institute of Siddha
